TheEdgeResearch
Home / Stocks / BIOE

Bio Essence Corporation (BIOE)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.18 ▲ +0.00%
Market Cap
$7.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
6.02
52-Wk Range
0.051-0.517
CEO
Yin Yan
Country
US
Currency
USD

Bio Essence Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Irvine, CA, US. The stock last traded at $0.18, up 0.00% on the session, giving a market capitalisation of $7.2M. On trailing twelve-month figures it carries a trailing P/E of 4.88, a net margin of 52.1%. Its beta of 6.02 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
4.88
Price / Sales
2.48
Price / Book
3.95
EV / EBITDA
5.34
Gross margin
69.7%
Operating margin
52.9%
Net margin
52.1%
Return on equity
—
Debt / equity
0.67
Current ratio
0.38
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
4
IPO date
2022-12-01
Headquarters
Irvine, CA, US
About Bio Essence Corporation

Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets. Furthermore, the company extends custom formulation and original equipment manufacturing (OEM) services to these practitioners and manufactures and distributes its own line of health supplements. Founded in 2000, Bio Essence Corporation maintains its corporate headquarters in Irvine, California.

Comparable companies

Bio Essence Corporation is most often compared with the following Healthcare names:

CRYMLMLLFLVVVNRPRRAFARDDTFREPCFRVVTFSTHZFUBQU
More research on BIOE
BIOE technical analysis BIOE TheEdge Score Compare against peers
Open full interactive analysis & DCF →